Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey. [electronic resource]
Producer: 20191224Description: 331-335 p. digitalISSN:- 2148-5607
- 2-Naphthylamine
- Adult
- Aged
- Anilides -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carbamates -- administration & dosage
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Kidney Failure, Chronic -- therapy
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Renal Dialysis
- Ritonavir -- administration & dosage
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Turkey
- Uracil -- administration & dosage
- Valine
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.